Breast Cancer Clinical Trial
Add-on Study for Protocol G200802 (NCT02463032): Effect of GTx-024 on Maximal Neuromuscular Function and Lean Body Mass
Summary
This is a multiple site, proof of concept feasibility study to describe the effect of GTx-024 9 or 18 mg on physical function in female subjects, from protocol G200802, with ER+/AR+ breast cancer.
Eligibility Criteria
Inclusion Criteria:
In screening for, and ultimately randomized into, protocol G200802
Give voluntary, written and signed, informed consent for this add-on study
Age 18 to 70 years old
Physically capable of mounting and riding a stationary bicycle
Subject agrees to not significantly alter physical activity or current physical training during the study period
Exclusion Criteria:
Subject has a concomitant medical condition that precludes adequate study treatment compliance or assessment, or increases subject risk, in the opinion of the Investigator
Subjects unwilling to or unable to comply with the protocol
Any other condition which per investigators' judgement may increase subject risk
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Seattle Washington, 98109, United States
How clear is this clinincal trial information?